EHS
EHS

Providers' concerns about behavior change don't justify withholding HIV PrEP



Preexposure prophylaxis (PrEP) for HIV is an antiretroviral pill that is over 90% effective in preventing HIV acquisition when taken as prescribed. A new Perspective, published in the February 7 issue of the New England Journal of Medicine, examines clinicians’ concerns and biases toward prescribing PrEP and suggests strategies to mitigate those biases. The Perspective, “Risk Compensation and Clinical Decision Making—The Case of HIV Preexposure Prophylaxis,” is coauthored by scientists at the Harvard Pilgrim Health Care Institute and Harvard Medical School, George Washington University, and Kaiser Permanente.

Source link

EHS
Back to top button